Total Payments
$9,095
2024 Payments
$321.79
Companies
42
Transactions
351
Medicare Patients
1,773
Medicare Billing
$362,215
Payment Breakdown by Category
Food & Beverage$9,069 (99.7%)
Education$25.88 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,069 | 348 | 99.7% |
| Education | $25.88 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,198 | 52 | $0 (2022) |
| ABBVIE INC. | $786.79 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $641.69 | 35 | $0 (2023) |
| GlaxoSmithKline, LLC. | $539.18 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $536.96 | 23 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $474.27 | 16 | $0 (2024) |
| Shionogi Inc | $436.94 | 22 | $0 (2024) |
| PFIZER INC. | $406.75 | 14 | $0 (2024) |
| Novo Nordisk Inc | $385.91 | 18 | $0 (2022) |
| Paratek Pharmaceuticals, Inc. | $275.82 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $321.79 | 13 | AIMMUNE THERAPEUTICS, INC. ($146.36) |
| 2023 | $927.19 | 43 | ABBVIE INC. ($252.15) |
| 2022 | $1,472 | 55 | ABBVIE INC. ($385.82) |
| 2021 | $1,081 | 44 | Boehringer Ingelheim Pharmaceuticals, Inc. ($257.41) |
| 2020 | $1,189 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($287.61) |
| 2019 | $1,147 | 44 | Boehringer Ingelheim Pharmaceuticals, Inc. ($426.29) |
| 2018 | $1,810 | 61 | Boehringer Ingelheim Pharmaceuticals, Inc. ($800.09) |
| 2017 | $1,146 | 43 | Boehringer Ingelheim Pharmaceuticals, Inc. ($363.04) |
All Payment Transactions
351 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/27/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Respiratory | ||||||
| 06/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: PAIN | ||||||
| 04/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: ANTIBIOTIC | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/12/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: PAIN | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/30/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/18/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 770 | 1,865 | $257,834 | $171,205 |
| 2022 | 2 | 434 | 1,058 | $157,740 | $86,539 |
| 2021 | 2 | 237 | 575 | $86,380 | $48,526 |
| 2020 | 2 | 332 | 636 | $90,725 | $55,945 |
Total Patients
1,773
Total Services
4,134
Medicare Billing
$362,215
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 297 | 1,096 | $119,294 | $79,186 | 66.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 98 | 347 | $51,943 | $37,695 | 72.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 264 | 301 | $58,928 | $35,937 | 61.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 100 | 105 | $23,990 | $16,615 | 69.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 16 | $3,680 | $1,772 | 48.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 205 | 778 | $93,340 | $51,309 | 55.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 229 | 280 | $64,400 | $35,231 | 54.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 106 | 417 | $50,040 | $28,157 | 56.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 131 | 158 | $36,340 | $20,369 | 56.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 186 | 217 | $48,825 | $27,978 | 57.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 146 | 419 | $41,900 | $27,967 | 66.7% |
About Dr. Jacquelyn Lahoud, M.D
Dr. Jacquelyn Lahoud, M.D is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1801114624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacquelyn Lahoud, M.D has received a total of $9,095 in payments from pharmaceutical and medical device companies, with $321.79 received in 2024. These payments were reported across 351 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,069).
As a Medicare-enrolled provider, Lahoud has provided services to 1,773 Medicare beneficiaries, totaling 4,134 services with total Medicare billing of $362,215. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Brooklyn, NY
- Active Since 05/05/2010
- Last Updated 08/31/2015
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801114624
Products in Payments
- JARDIANCE (Drug) $2,274
- VRAYLAR (Drug) $526.88
- XARELTO (Drug) $499.53
- Fetroja (Drug) $436.94
- TRELEGY ELLIPTA (Drug) $359.99
- NUZYRA (Drug) $275.82
- JANUVIA (Drug) $269.12
- Ozempic (Drug) $257.64
- FARXIGA (Drug) $240.57
- NURTEC ODT (Drug) $231.28
- Vascepa (Drug) $212.16
- BREZTRI (Drug) $173.40
- ZENPEP (Drug) $146.36
- PROPEL (Device) $145.83
- XIFAXAN (Drug) $141.15
- UBRELVY (Drug) $128.70
- Aimovig (Biological) $123.21
- AJOVY (Biological) $119.89
- EUCRISA (Drug) $118.79
- WATCHMAN (Device) $114.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Andre Brutus
Infectious Disease — Payments: $379,075
Infectious Disease $379,075
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Olga Badem, Md, MD
Infectious Disease — Payments: $6,500
Infectious Disease $6,500